Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-08-13
2009-06-16
Crouch, Deborah (Department: 1632)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007100
Reexamination Certificate
active
07547522
ABSTRACT:
The invention relates to the genetic manipulation of non-human animals. More particularly, the invention relates to genetic manipulation of non-human animals to be used for xenotransplantation. The invention provides a method of selecting GGTA 1 null cells, a viable GGTA 1 null swine, methods for making such swine, and methods of using cells, tissues and organs of such swine for xenotransplantation.
REFERENCES:
patent: 5821117 (1998-10-01), Sandrin et al.
patent: 5849991 (1998-12-01), D'Aspice et al.
patent: 6153428 (2000-11-01), Gustafsson et al.
patent: 6166288 (2000-12-01), Diamond et al.
patent: 6331658 (2001-12-01), Cooper et al.
patent: 6413769 (2002-07-01), Gustafsson et al.
patent: WO-95/20661 (1995-08-01), None
patent: WO 95/28412 (1995-10-01), None
patent: WO 97/16064 (1997-05-01), None
patent: WO 01/88096 (2001-11-01), None
Evans, R.W., “Coming to Terms with Reality: Why Xenotransplantation is a necessity”, Xenotransplantation, J.L. Platt, Ed., ASM Press, Wash., DC, 29-51 (2001).
Lambrigts et al., “Discordant Organ Xenotransplantation in Primates”, Transplantation, 66(5):547-561 (1998).
Costa et al., “Expression of the Human 1,2-Fucosyltransferase in Transgenic pigs Modifies the Cell Surface Carbohydrate Phenotype and Confers Resistance to Human Serum-Mediated Cytolysis”, FASEB J., 13:1762-1773 (1999).
Miyagawa et al., “Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig”, J. Biol. Chem., 276(42):39310 39319 (2001).
Thall et al., “Oocyte Galα1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 are Not Required for Fertilization in the Mouse”, J. Biol. Chem., 270(37):21437-21440 (1995).
Park et al., Anim. Biotech., In Press (2001).
Dai et al., “Targeted Disruption of the α1,3-Galactosyltransferase Gene in Cloned Pigs” Nature Biotechnol., 20(3):251-255 (2002).
Lai et al., “Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning” Science, 295:1089-1092 (2002).
Bondioli et al., “Cloned Pigs Generated From Cultured Skin Fibroblasts Derived From a H-Transferase Transgenic Boar”, Mol. Reproduc. Dev., 60:189-195 (2001).
Sachs et al., “Transplantation in Miniature Swine”, Transplantation, 22(6):559-567 (1976).
Nozawa, S. et al., “Characteristics of Immunoglobulin Gene Usage of the Xenoantibody Binding to . . . ” Transplantation, 72(1):147-155 (2001).
Ayares, D. et al., “Cloning Pigs Deficient in Alpha 1,3 Galactosyltransferase” Graft, 4(1):80-82 (2001).
Gock, H. et al., “Deleting the Gal Epitope from the Donor Pig” Graft, 4(1):76-77 (2001).
Miyagawa, S. et al., “Masking and Reduction of the Galactose-Alpha 1,3-Galactose (alpha-Gal) Epitope, the Major Xenoantigen in Swine, by the Glycosyltransferase Gene Transfection”, Biochemical and Biophysical Research Communications, 264:611-614 (1999).
Sao, H. et al., “A New Marrow T Cell Depeletion Method Using Anti-CD6-Monoclonal Antibody-Conjugated Magnetic Beads and its Clinical Application for Prevention of Actue Graft-vs.-Host Disease in Allogeneic Bone Marrow Transplantation: Results of a Phase I-II Trial”, International Journal of Hematology, 69:27-35 (1999).
Polejaeva, I.A. et al., “Cloned Pigs Produced by Nuclear Transfer from Adult Somatic Cells”, Nature, 407:86-90 (2000).
Onishi, A. et al., “Pig Cloning by Mocroinjection of Fetal fibroblast Neclei”, Science, 289:1188-1190 (2000).
Betthauser, J. et al., “Production of Cloned Pigs from In Vitro Systems”, Nature Biotechnology, 18:1055-1059 (2000).
McCreath, K.J. et al., “Production of Gene-Targeted Sheep by Nuclear Transfer From Somatic Cells”, Nature, 405:1066-1069 (2000).
McKenzie et al., “Strategies to overcome hyperacute rejection of pig-to-human xenografts,” Transplantation Proceedings, vol. 29, No. 1/2, pp. 973-974 (1996).
R.G. Tearle et al., “The [alpha]-1,3-Galactosyltransferase Knockout Mouse: Implications for Xenotransplantation [Rapid Communication]”,Transplantation(Baltimore), vol. 61, No. 1, pp. 1-9 (1996).
A.D. Thall, “Generation of α 1,3Galactosyltransferase Deficient Mice”,Sub-Cellular Biochemistry, vol. 32, pp. 259-279 (1999).
A. Sepp et al., “Inhibition of Expression of the Galα1-3Gal Epitope on Porcine Cells Using an Intracellular Single-Chain Antibody Directed Against α1,3Galactosyltransferase”,Journal of Immunological Methods(Elsevier Science Publishers B.V., Amsterdam, NL), vol. 231, No. 1-2, pp. 191-205 (Dec. 10, 1999).
C.J. Phelps et al., “Production of α1,3-Galactosyltransferase Deficient Pigs”,Science, American Association for the Advancement of Science, vol. 299, pp. 411-414 (Jan. 17, 2003).
Choate Hall & Stewart LLP
Crouch Deborah
Furman Margo H.
Immerge Biotherapeutics, Inc.
LandOfFree
Method to enrich for α(1,3)-galactosyltransferase null... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to enrich for α(1,3)-galactosyltransferase null..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to enrich for α(1,3)-galactosyltransferase null... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4146526